Tue.Jan 25, 2022

Gene editing startup Metagenomi raises $175M to advance research pipeline

Bio Pharma Dive

The biotech raised the Series B round during "probably one of the worst biotech markets" emerging drugmakers have faced in some time, a Metagenomi executive told BioPharma Dive

The era of “consumer healthcare”?

World of DTC Marketing

Clunky, costly, highly regulated health systems, often dominated by rent-seeking middlemen, are being shaken up by firms that target patients directly, meet them where they are—which is increasingly online—and give them more control over how to access care.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

J&J 'constantly looking' at biotech M&A, but focused on small, mid-sized deals

Bio Pharma Dive

Despite sliding stock prices, biotechs aren't "on sale," J&J CFO Joe Wolk said Tuesday. "It's really hard to say whether there's been a capitulation, or a recognition, that values have come down "

Sales 139

Plastic snowfall in the Alps

Scienmag

In a new study, Empa researcher Dominik Brunner, together with colleagues from Utrecht University and the Austrian Central Institute for Meteorology and Geophysics, is investigating how much plastic is trickling down on us from the atmosphere.

2022 Research: The Rapid Rise of Ocean Freight Visibility

Download this a benchmark study from FourKites and The Journal of Commerce exploring how international shippers’ usage of global supply chain visibility technology has evolved since the onset of global disruptions caused by COVID-19.

With new trial, Pfizer and BioNTech will test whether an omicron vaccine is needed

Bio Pharma Dive

The trial, which will enroll nearly 1,500 people, could help determine whether a variant-specific shot is more effective than an additional booster of Pfizer's original vaccine

Trials 130

More Trending

Sierra Oncology records success in late-stage study of bone cancer drug

Bio Pharma Dive

The biotech said it plans to soon submit the drug, which it acquired for cheap from Gilead three years ago, to the Food and Drug Administration for approval

Drugs 130

Preparing the next generation for business succession: Telfer’s Family Enterprise Legacy Institute

Scienmag

It’s advice Logan Roy, the fictional patriarch from the TV program Succession, would not want to hear but must heed: family businesses must prepare the next generation or risk watching their businesses crumble.

83

Digital therapeutics: a new frontier of medicine

Pharma Phorum

The area of digital therapeutics is growing rapidly, and in this piece Ben Hargreaves examines why this is the case, how broadly these therapies can be applied and why investment in the area is mounting.

E-bike incentive programs in North America: New online tracker from Portland State University

Scienmag

For governments and clean energy advocates looking to encourage people to use e-bikes for transportation, a new online tool from Portland State University researchers offers an overview of the existing incentive programs in the United States and Canada.

An Innovative & Creative Problem Solver Approach to Selling in the Medical Device Space

Speaker: Steve Goldstein, Sales Leader

Currently in sales or involved in a business that depends on strong sales results? Join Steve Goldstein, Sales Success Coach, Motivational Speaker and Medical Device Sales Leader from Gold Selling LLC. You will absorb critical strategies to become a trusted partner in greater sales success.

PolyPhotonix raises $10m to trial sleep mask for diabetic eye disease

Pharma Phorum

The UK company behind a sleep mask that aims to treat sight-robbing complications of diabetes has secured $10 million in funding that will be used to run trials of the medical device.

Viral proteins join forces to lower plants’ defense ‘shields’

Scienmag

PULLMAN, Wash. – New research, led by Washington State University scientists, into how viral proteins interact and can be disabled holds promise to help plants defend themselves against viruses—and ultimately prevent crop losses.

Utilising real-time data to improve customer engagement

Pharma Phorum

Oskar Möbert, Vice President OpenData Europe at Veeva Systems, tells us how they are reimagining customer reference data to boost pharma rep productivity, enable more personalised engagement, and increase patient reach.

Less psychosocial problems in patients with dementia during second lockdown

Scienmag

Amsterdam, January 19, 2022: The covid-19 pandemic still poses enormous social challenges. People with cognitive impairments (problems with, for example, memory and concentration) and dementia are doubly affected by this pandemic. On the one hand, they have direct risk of severe Covid-19 symptoms.

Mandatory COVID Vaccination Policy Template

The federal government is developing a rule requiring employers with more than 100 employees ensure their workers are vaccinated or produce a negative COVID test weekly before entering the workplace. So, what can your organization do to prepare? Get Paycor’s COVID Vaccination Policy Template to help communicate important details to your employees.

FDA approves IND for clinical trial evaluating CBD-based drug

Outsourcing Pharma

The agency has given the go-ahead on an IND application for a study evaluating Ananda Scientificâs Nantheia ATL5, a candidate for treating opioid use disorder. Clinical Development

Finding the tipping point for coastal wetlands

Scienmag

DURHAM, N.C. — The Albemarle-Pamlico Peninsula covers more than 2,000 square miles on the North Carolina coastal plain, a vast expanse of forested swamps and tea-colored creeks.

83

Multi-national studies call for informed approach: Firma Clinical Research

Outsourcing Pharma

Am expert from the CRO discusses unique challenges associated with running clinical trials that stretch across national boarders and how to conquer them. Clinical Development

Hospitalization for COVID-19 linked to greater risk of later readmission or death

Scienmag

A large study conducted in England found that, compared to the general population, people who had been hospitalized for COVID-19—and survived for at least one week after discharge—were more than twice as likely to die or be readmitted to the hospital in the next several months.

Which pharmaceutical companies have the most drug patents in Australia?

Drug Patent Watch

This chart shows the pharmaceutical companies with the most patents in Australia. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…. The post Which pharmaceutical companies have the most drug patents in Australia?

Drugs 82

English songs are an effective learning tool for learning English vocabulary, says Pusan National University researcher

Scienmag

Music is often considered a universal language, as it crosses language barriers and connects people all over the world with ease. In fact, songs are popularly used in foreign language classrooms as a means to expose students to authentic content in the language being taught.

FDA bans use of Lilly, Regeneron COVID drugs due to Omicron

Pharma Phorum

The FDA has limited the use of COVID-19 antibody therapies developed by Eli Lilly and Regeneron, on the back of data suggesting they have are “highly unlikely” to be effective against the now-dominant Omicron variant.

Professor aims to improve gender affirming surgery through research

Scienmag

Raffaella De Vita, professor and associate department head in the Department of Biomedical Engineering and Mechanics in the College of Engineering, has been awarded a National Science Foundation (NSF) award to study the biomechanics of gender affirming surgery.

Pfizer starts dosing patients with its Omicron COVID shot

Pharma Phorum

Pfizer and partner BioNTech have started their clinical trial of a new version of their COVID-19 vaccine that has been specifically designed to protect against the Omicron variant.

Study details changes in omicron’s spike protein

Scienmag

An international team of scientists has determined the precise structural changes in the spike protein of the omicron variant. Their observations explain how the virus is able to evade antibodies against previous variants and still remain highly infectious.

FDA approves Nucala prefilled syringe for children with severe asthma

BioPharma Reporter

GlaxoSmithKline plc (GSK) says the US Food and Drug Administration (FDA) has approved its anti-IL-5 biologic Nucala (mepolizumab) in a 40 mg pre-filled syringe for children aged 6 to 11 years old with severe eosinophilic asthma (SEA). Markets & Regulations

Altruism towards offspring: a study reveals details in diatoms’ fitness

Scienmag

Diatoms, single-celled algae typically enshrined in a siliceous cell wall, generally act as opportunistic organisms, reproducing uncontrollably in the presence of favorable conditions, but are also able to make altruistic decisions acting for the good of the community.

82

EdiGene enters R&D collaboration to develop hematopoietic stem cell regenerative therapies

BioPharma Reporter

Biotech EdiGene has announced an R&D collaboration with Haihe Laboratory of Cell Ecosystem to develop hematopoietic stem cell regenerative therapies and platform technology. Bio Developments

Can reactor fuel debris be safely removed from Fukushima Daiichi?

Scienmag

Highly radioactive fuel debris remains in the reactors. Credit: Satoshi Utsunomiya Highly radioactive fuel debris remains in the reactors. Decommissioning and clean-up are ongoing at the Fukushima Daiichi Nuclear Power Plant (FDNPP); however, many difficult problems remain unaddressed.

Innovative phase 2 trial targets advanced liver cancer

Pharma Times

The UCL study will evaluate the safety and effectiveness of MTL-CEBPA in combination with second line standard of care sorafenib versus the use of sorafenib in isolation

The Work of the Future: Building Better Jobs in an Age of Intelligent Machines

Scienmag

“For too long, American workers have been left behind. Business leaders have a responsibility to their workers to understand the challenges and opportunities associated with building better jobs.

Yposkesi leveraging expertise of major shareholder, new facility build on schedule

BioPharma Reporter

The construction of Yposkesiâs second facility is on track, the French CDMO has confirmed. Upstream Processing

78

Scientists discover new avian immunological pathway

Scienmag

RIVERSIDE, Calif.